Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Total Current Liabilities (2023 - 2026)

Camp4 Therapeutics' Total Current Liabilities history spans 3 years, with the latest figure at $15.5 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 61.64% to $15.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.5 million, a 61.64% increase, with the full-year FY2025 number at $15.5 million, up 61.64% from a year prior.
  • Total Current Liabilities hit $15.5 million in Q4 2025 for Camp4 Therapeutics, up from $7.9 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for CAMP hit a ceiling of $15.5 million in Q4 2025 and a floor of $6.4 million in Q1 2025.
  • Historically, Total Current Liabilities has averaged $9.5 million across 3 years, with a median of $7.9 million in 2025.
  • The widest YoY moves for Total Current Liabilities: up 61.64% in 2025, down 33.19% in 2025.
  • Tracing CAMP's Total Current Liabilities over 3 years: stood at $7.8 million in 2023, then grew by 22.94% to $9.6 million in 2024, then soared by 61.64% to $15.5 million in 2025.
  • Business Quant data shows Total Current Liabilities for CAMP at $15.5 million in Q4 2025, $7.9 million in Q3 2025, and $7.3 million in Q2 2025.